These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 16368183)
1. A generalized numerical approach to rapid-equilibrium enzyme kinetics: application to 17beta-HSD. Kuzmic P Mol Cell Endocrinol; 2006 Mar; 248(1-2):172-81. PubMed ID: 16368183 [TBL] [Abstract][Full Text] [Related]
2. A generalized numerical approach to steady-state enzyme kinetics: applications to protein kinase inhibition. Kuzmic P Biochim Biophys Acta; 2010 Mar; 1804(3):635-41. PubMed ID: 19716937 [TBL] [Abstract][Full Text] [Related]
3. Application of the Van Slyke-Cullen irreversible mechanism in the analysis of enzymatic progress curves. Kuzmic P Anal Biochem; 2009 Nov; 394(2):287-9. PubMed ID: 19627979 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of 17beta-hydroxysteroid dehydrogenases by phytoestrogens: comparison with other steroid metabolizing enzymes. Deluca D; Krazeisen A; Breitling R; Prehn C; Möller G; Adamski J J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):285-92. PubMed ID: 15860272 [TBL] [Abstract][Full Text] [Related]
5. DynaFit--a software package for enzymology. Kuzmič P Methods Enzymol; 2009; 467():247-280. PubMed ID: 19897096 [TBL] [Abstract][Full Text] [Related]
8. Program DYNAFIT for the analysis of enzyme kinetic data: application to HIV proteinase. Kuzmic P Anal Biochem; 1996 Jun; 237(2):260-73. PubMed ID: 8660575 [TBL] [Abstract][Full Text] [Related]
9. The derivation of a potential transition state for the reduction reaction catalysed by 17beta-hydroxysteroid dehydrogenase--an approximate representation of its active site for use in drug design and discovery. Owen CP; Ahmed S Biochem Biophys Res Commun; 2004 May; 318(1):131-4. PubMed ID: 15110763 [TBL] [Abstract][Full Text] [Related]
10. 4,5-Disubstituted cis-pyrrolidinones as inhibitors of type II 17beta-hydroxysteroid dehydrogenase. Part 2. SAR. Gunn D; Akuche C; Baryza J; Blue ML; Brennan C; Campbell AM; Choi S; Cook J; Conrad P; Dixon B; Dumas J; Ehrlich P; Gane T; Joe T; Johnson J; Jordan J; Kramss R; Liu P; Levy J; Lowe D; McAlexander I; Natero R; Redman AM; Scott W; Seng T; Sibley R; Wang M; Wang Y; Wood J; Zhang Z Bioorg Med Chem Lett; 2005 Jun; 15(12):3053-7. PubMed ID: 15890515 [TBL] [Abstract][Full Text] [Related]
11. Structural basis for inhibition of 17β-hydroxysteroid dehydrogenases by phytoestrogens: The case of fungal 17β-HSDcl. Cassetta A; Stojan J; Krastanova I; Kristan K; Brunskole Švegelj M; Lamba D; Lanišnik Rižner T J Steroid Biochem Mol Biol; 2017 Jul; 171():80-93. PubMed ID: 28259640 [TBL] [Abstract][Full Text] [Related]
12. Analysis of residuals from enzyme kinetic and protein folding experiments in the presence of correlated experimental noise. Kuzmic P; Lorenz T; Reinstein J Anal Biochem; 2009 Dec; 395(1):1-7. PubMed ID: 19524543 [TBL] [Abstract][Full Text] [Related]
13. Pharmacophore modelling of 17beta-HSD1 enzyme based on active inhibitors and enzyme structure. Karkola S; Alho-Richmond S; Wahala K Mol Cell Endocrinol; 2009 Mar; 301(1-2):225-8. PubMed ID: 18822344 [TBL] [Abstract][Full Text] [Related]
14. Model building and model checking for biochemical processes. Antoniotti M; Policriti A; Ugel N; Mishra B Cell Biochem Biophys; 2003; 38(3):271-86. PubMed ID: 12794268 [TBL] [Abstract][Full Text] [Related]
16. Synthesis, biochemical evaluation and rationalisation of the inhibitory activity of a series of 4-hydroxyphenyl ketones as potential inhibitors of 17beta-hydroxysteroid dehydrogenase type 3 (17beta-HSD3). Lota RK; Dhanani S; Owen CP; Ahmed S Bioorg Med Chem Lett; 2006 Sep; 16(17):4519-22. PubMed ID: 16797984 [TBL] [Abstract][Full Text] [Related]
17. Estradiol-adenosine hybrid compounds designed to inhibit type 1 17beta-hydroxysteroid dehydrogenase. Poirier D; Boivin RP; Tremblay MR; Bérubé M; Qiu W; Lin SX J Med Chem; 2005 Dec; 48(26):8134-47. PubMed ID: 16366595 [TBL] [Abstract][Full Text] [Related]
18. Identification of a novel series of tetrahydrodibenzazocines as inhibitors of 17beta-hydroxysteroid dehydrogenase type 3. Fink BE; Gavai AV; Tokarski JS; Goyal B; Misra R; Xiao HY; Kimball SD; Han WC; Norris D; Spires TE; You D; Gottardis MM; Lorenzi MV; Vite GD Bioorg Med Chem Lett; 2006 Mar; 16(6):1532-6. PubMed ID: 16386902 [TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and biological evaluation of (hydroxyphenyl)naphthalene and -quinoline derivatives: potent and selective nonsteroidal inhibitors of 17beta-hydroxysteroid dehydrogenase type 1 (17beta-HSD1) for the treatment of estrogen-dependent diseases. Frotscher M; Ziegler E; Marchais-Oberwinkler S; Kruchten P; Neugebauer A; Fetzer L; Scherer C; Müller-Vieira U; Messinger J; Thole H; Hartmann RW J Med Chem; 2008 Apr; 51(7):2158-69. PubMed ID: 18324762 [TBL] [Abstract][Full Text] [Related]
20. Mapping of steroids binding to 17 beta-hydroxysteroid dehydrogenase type 1 using Monte Carlo energy minimization reveals alternative binding modes. Blanchet J; Lin SX; Zhorov BS Biochemistry; 2005 May; 44(19):7218-27. PubMed ID: 15882060 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]